or
forgot password

Computer Assisted Volumetric Analysis of CT-Identified Metastatic Pulmonary Or Hepatic Lesions


N/A
18 Years
N/A
Not Enrolling
Both
Metastatic Cancer

Thank you

Trial Information

Computer Assisted Volumetric Analysis of CT-Identified Metastatic Pulmonary Or Hepatic Lesions


This is a Pilot Study that will evaluate if metastatic liver and lung tumor measurements
made by the MeVis™ software program can provide more accurate information about the size and
changes of the tumor compared to the current evaluation method, RECIST(Response Evaluation
In Solid Tumors). This study will also collect information about the kind of treatment each
subject receives.

Subjects will receive standard of care surveillance CT examinations(a baseline to document
tumor size and interval CT exams as indicated by the Oncology Department Protocols); the
tumor will be measured according to the current standard-RECIST by Radiology personnel not
involved in the study. The CT data will then be analyzed by investigators using the MeVis™
software.


Inclusion Criteria:



- Subjects with cancer metastatic to either the liver or lungs

- Subjects Scheduled for regular CT surveillance examinations

- Subjects with life expectancy of at least 6 months

Exclusion Criteria:

- Age <18 years

- No written informed consent

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

This Study Assessed the Ability of MeVis™ Volumetry Software to Reproducibly Measure the Changes in Metastatic Hepatic and Pulmonary Lesions

Outcome Description:

Due to the low enrollment for this project the data collected is not sufficient to provide any significant conclusion to the primary outcome hypothesis. Due to lack of participants. No significant findings are reported at this time.

Outcome Time Frame:

As long as treatment is being assessed by CT examinations

Safety Issue:

No

Principal Investigator

Christoph Wald, M.D., Ph.D

Investigator Role:

Principal Investigator

Investigator Affiliation:

Lahey Clinic, Inc.

Authority:

United States: Institutional Review Board

Study ID:

2007-017

NCT ID:

NCT00676455

Start Date:

February 2007

Completion Date:

January 2009

Related Keywords:

  • Metastatic Cancer
  • CT Software
  • MeVis™
  • Metastatic pulmonary and hepatic lesion growth
  • Neoplasm Metastasis
  • Neoplasms
  • Neoplasms, Second Primary

Name

Location
Lahey Clinic, Inc. Burlington, Massachusetts  01805